Mr. Chair, with a final question, I'll turn to Dr. Bechard.
Dr. Bechard, I'm a member of Parliament from London, Ontario, which is home to the Bethanys Hope Foundation, focusing on a rare disease called metachromatic leukodystrophy. I wonder if your organization has any particular thoughts on rare diseases, particularly within the framework of how we might approach pharmacare. I know that in last year's budget there was a move in this direction, to support individuals struggling with rare diseases in their families. But have you or your organization any thoughts that you could offer in that regard?